Literature DB >> 3120204

Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder.

A S de Villiers1, V A Russell, M E Carstens, C Aalbers, C A Gagiano, D O Chalton, J J Taljaard.   

Abstract

Plasma levels of cortisol, norepinephrine (NE), and 3-methoxy-4-hydroxyphenylglycol (MHPG) were found to be significantly higher in 16 drug-free patients with primary, unipolar major depressive disorder than in 20 controls. Plasma free MHPG and basal cortisol levels showed a significant positive correlation in the controls, but not in the patients. There were, however, significant positive correlations between cortisol and NE, as well as between NE and free MHPG levels in the patients. No correlations were observed between patient plasma NE levels and platelet alpha 2-adrenoceptor or lymphocyte beta-adrenoceptor Kd or Bmax values. These peripheral measures of noradrenergic function are proposed as useful markers for patients with primary, unipolar major depressive disorder with melancholia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120204     DOI: 10.1016/0165-1781(87)90100-4

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Lack of interaction between alpha 2-adrenoceptors and dopamine D2-receptors in mediating their inhibitory effects on [3H]dopamine release from rat nucleus accumbens slices.

Authors:  V A Russell; M C Lamm; J J Taljaard
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

2.  The effect of intrahippocampal injection of kainic acid on corticosterone release in rats.

Authors:  W M Daniels; A Jaffer; A H Engelbrecht; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

3.  Effect of corticosterone on noradrenergic nuclei in the pons-medulla and [3H]NA release from terminals in hippocampal slices.

Authors:  A S de Villiers; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1992-03       Impact factor: 3.996

4.  Effect of single and repeated electroconvulsive shock on the hypothalamic-pituitary-adrenal axis and plasma catecholamines in rats.

Authors:  A B Thiagarajan; C H Gleiter; I N Mefford; R L Eskay; D J Nutt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Coexisting dysregulations of both the sympathoadrenal system and hypothalamic-pituitary-adrenal-axis in melancholia.

Authors:  M Maes; B Minner; E Suy; C Vandervorst; J Raus
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Alpha 2- and beta-adrenergic stimulation of corticosterone secretion in rats.

Authors:  W M Daniels; A Jaffer; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1993-02       Impact factor: 3.996

7.  The effect of partial noradrenergic denervation on corticosterone secretion in the rat.

Authors:  W M Daniels; A Jaffer; A Searson; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1989-12       Impact factor: 3.996

8.  Lack of effect of bilateral locus coeruleus lesion and antidepressant treatment on gamma-aminobutyric acidB receptors in the rat frontal cortex.

Authors:  A H Engelbrecht; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

9.  Which psychological, psychophysiological, and anthropometric factors are connected with life events, depression, and quality of life in patients with cardiovascular disease.

Authors:  Milos Slepecky; Antonia Kotianova; Jan Prasko; Ivan Majercak; Erika Gyorgyova; Michal Kotian; Marta Zatkova; Marta Popelkova; Marie Ociskova; Ingrid Tonhajzerova
Journal:  Neuropsychiatr Dis Treat       Date:  2017-08-04       Impact factor: 2.570

10.  Tremors in white rhinoceroses (<i>Ceratotherium simum</i>) during etorphine-azaperone immobilisation.

Authors:  Stephanie S De Lange; Andrea Fuller; Anna Haw; Markus Hofmeyr; Peter Buss; Michele Miller; Leith C R Meyer
Journal:  J S Afr Vet Assoc       Date:  2017-02-24       Impact factor: 1.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.